Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
Solta Medical, Inc. (NASDAQ: SLTM) today announced that it has commenced an underwritten public offering of its common stock. Canaccord Genuity is acting as sole book-running manager and Roth Capital Partners is acting as co-manager. Solta Medical expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering solely to cover over-allotments, if any. The offering is subject to customary conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Solta Medical currently intends to use the net proceeds from the offering for general corporate purposes
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.